Anthony Chiaravalloti, MD
Procedural Dermatology · East Syracuse, NYNPI 1598178378
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $61,387 of the $89,711 with a category attached, or 68.4%. 29 manufacturers reported payments, led by Sun Pharmaceutical Industries Inc. at 58.1% of the total.
Across 848 payments — averaging $105.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sun Pharmaceutical Industries Inc.$52K
- Mimedx Group, Inc.$20K
- AbbVie$5K
- Novartis$2K
- Incyte Corporation$2K
- Johnson & Johnson$1K
- plus $7K from 23 others
What the payments were for
- Consulting fees$2,8333%
- Speaking & faculty fees$61,38768%
- Travel & lodging$5,5466%
- Food & beverage$19,54622%
- Education$3990%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sun Pharmaceutical Industries Inc. | 116 | $52,078 |
| Mimedx Group, Inc. | 25 | $20,001 |
| AbbVie | 224 | $5,298 |
| Novartis | 87 | $2,087 |
| Incyte Corporation | 74 | $1,895 |
| Johnson & Johnson | 56 | $1,097 |
| Regeneron Healthcare Solutions, Inc. | 28 | $1,095 |
| Amgen | 31 | $687 |
| UCB, Inc. | 22 | $627 |
| LEO Pharma Inc. | 24 | $618 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 33 | $490 |
| Pfizer | 17 | $483 |
| Sanofi | 17 | $469 |
| E.r. Squibb & Sons, L.L.C. | 10 | $460 |
| VYNE Pharmaceuticals Inc. | 23 | $441 |
| Genentech USA, Inc. | 13 | $431 |
| Lilly USA, LLC | 17 | $363 |
| Galderma Laboratories, L.p. | 6 | $248 |
| Janssen Scientific Affairs, LLC | 2 | $147 |
| Dermavant Sciences, Inc. | 3 | $143 |
| Stemline Therapeutics Inc. | 1 | $139 |
| Bristol Myers Squibb | 6 | $125 |
| Sanofi-aventis U.S. LLC | 1 | $80 |
| Boehringer Ingelheim | 3 | $65 |
| Prugen, Inc. Pharmaceuticals | 5 | $47 |
| Amneal Pharmaceuticals LLC | 1 | $33 |
| Dermira, Inc. | 1 | $26 |
| Sandoz | 1 | $22 |
| DUSA Pharmaceuticals, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$89,711 in reported general payments places this provider in the 85th percentile of 69 procedural dermatology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OdomzoSonidegib Phosphate | 16 | $220,967 |
| Humira(Cf) PenAdalimumab | 13 | $88,550 |
| Doxycycline Hyclate | 11 | $48 |
| Cephalexin | 15 | $31 |
Paid to pharmacies, not to this prescriber.
Other procedural dermatology in East Syracuse
- Joseph SchwartzTroy$470K
- Michelle HenryNew York$460K
- Jerry ShapiroNew York$414K
- Jared JagdeoBrooklyn$362K
- Dendy EngelmanNew York$292K
- Evan RiederNew York$210K
- Daniel Belkin-HollandNew York$208K
- Suzanne Sirota-RozenbergWoodmere$122K
- Robert BacigalupiGarden City$109K
- Ariel OstadNew York$36K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.